NTLA
Intellia Therapeutics, Inc.In Vitro & In Vivo Diagnostic Substances · SIC 2835CIK 1652130Held by 4 tracked managersEDGAR filings ↗10-K/10-Q ↗
Shares held by quarter · Q1 2026–Q2 2026 (2 quarters stored)
ARK Investment Management
RA Capital Management
Renaissance Technologies
Baker Bros. Advisors
Stored snapshots only: quarters before the earliest stored filing are not shown, and the first stored quarter is not the start of any position.
Position history by manager
ManagerLatest sharesHistory